Entourage Health (CVE:ENTG) Reaches New 1-Year Low – Time to Sell?
by Doug Wharley · The Cerbat GemShares of Entourage Health Corp. (CVE:ENTG – Get Free Report) hit a new 52-week low during trading on Monday . The stock traded as low as C$0.01 and last traded at C$0.01, with a volume of 41126 shares trading hands. The stock had previously closed at C$0.01.
Entourage Health Stock Performance
The company has a current ratio of 0.10, a quick ratio of 0.91 and a debt-to-equity ratio of 2,914.72. The business’s 50 day moving average is C$0.01 and its two-hundred day moving average is C$0.01. The company has a market cap of C$3.08 million, a PE ratio of -0.07 and a beta of 1.08.
About Entourage Health
Entourage Health Corp. processes, produces, and distributes cannabis products for medical, adult-use, and bulk sales markets in Canada. It offers cannabis products, such as dried flower, pre-rolls, vapes, cannabis oils, topicals, soft chews, chewing gum, and micro inhalers. The company sells its products under the Color Cannabis, Saturday Cannabis, Starseed Medicinal, Dime Bag, Syndicate, Mary’s Medicinals, and Royal City Cannabis brand names.
Featured Articles
- Five stocks we like better than Entourage Health
- Transportation Stocks Investing
- Is Monolithic Power Systems a Screaming Buy After Near 40% Drop?
- Want to Profit on the Downtrend? Downtrends, Explained.
- Applied Materials Market Capitulates: Now is the Time to Buy
- 3 Small Caps With Big Return Potential
- 3 Ultra-High Dividend Yield Stocks for the New Year